Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men in the U.S. The American Cancer Society estimates there were 192,000 new cases last year ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

A research team has created a new machine-learning framework that distinguishes between low- and high-risk prostate cancer, according to a paper published in Scientific Reports. The framework aims to ...

Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors ...

New test could eliminate need for painful biopsies. Gen-Probe (Nasdaq: GPRO) appears to be on the right track with its experimental prostate cancer test, judging from a raft of recent clinical studies ...

Urologists who buy their own equipment to provide expensive radiation treatment are more likely to use it to treat prostate cancer even when the benefit for patients is unclear, research shows.